CA2304925A1 - Polyucleotides de borrelia burgdorferi et sequences correspondantes - Google Patents

Polyucleotides de borrelia burgdorferi et sequences correspondantes Download PDF

Info

Publication number
CA2304925A1
CA2304925A1 CA002304925A CA2304925A CA2304925A1 CA 2304925 A1 CA2304925 A1 CA 2304925A1 CA 002304925 A CA002304925 A CA 002304925A CA 2304925 A CA2304925 A CA 2304925A CA 2304925 A1 CA2304925 A1 CA 2304925A1
Authority
CA
Canada
Prior art keywords
polypeptide
sequence
present
borrelia
sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002304925A
Other languages
English (en)
Inventor
Claire Fraser
Owen R. White
Rebecca Clayton
Brian A. Dougherty
Raju Lathigra
Hamilton O. Smith
Sherwood Casjens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
MedImmune LLC
University of Utah Research Foundation Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2304925A1 publication Critical patent/CA2304925A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Cette invention se rapporte à des séquences polynucléotidiques du génome de Borrelia Burgdorferi, à des séquences polypeptidiques codées par ces séquences polynucléotidiques, aux polynucléotides et polypeptides correspondants, à des vecteurs et hôtes comprenant ces polynucléotides, ainsi qu'à des immunodosages et d'autres utilisations de ceux-ci. Cette invention se rapporte en outre à des informations, relatives à ces séquences de polynucléotides et de polypeptides, mémorisées sur des supports lisibles par voie informatique, ainsi qu'à des systèmes informatiques et à des procédés qui facilitent l'utilisation de ces informations.
CA002304925A 1997-06-20 1998-06-18 Polyucleotides de borrelia burgdorferi et sequences correspondantes Abandoned CA2304925A1 (fr)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US5035997P 1997-06-20 1997-06-20
US60/050,359 1997-06-20
US5337797P 1997-07-22 1997-07-22
US5334497P 1997-07-22 1997-07-22
US60/053,344 1997-07-22
US60/053,377 1997-07-22
US5748397P 1997-09-03 1997-09-03
US60/057,483 1997-09-03
PCT/US1998/012764 WO1998058943A1 (fr) 1997-06-20 1998-06-18 Polyucleotides de borrelia burgdorferi et sequences correspondantes

Publications (1)

Publication Number Publication Date
CA2304925A1 true CA2304925A1 (fr) 1998-12-30

Family

ID=27489331

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002294568A Abandoned CA2294568A1 (fr) 1997-06-20 1998-06-18 Vaccins contre la maladie de lyme
CA002304925A Abandoned CA2304925A1 (fr) 1997-06-20 1998-06-18 Polyucleotides de borrelia burgdorferi et sequences correspondantes

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA002294568A Abandoned CA2294568A1 (fr) 1997-06-20 1998-06-18 Vaccins contre la maladie de lyme

Country Status (4)

Country Link
EP (2) EP1012157A1 (fr)
AU (2) AU8153498A (fr)
CA (2) CA2294568A1 (fr)
WO (2) WO1998059071A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2303409A1 (fr) * 1997-09-10 1999-03-18 Yale University Synthetase d'arnt de lysyle de classe-i
GB9808423D0 (en) * 1998-04-22 1998-06-17 Glaxo Group Ltd Bacterial polypeptide family
EP1117783B1 (fr) * 1998-09-30 2010-02-17 Agensys, Inc. Gene exprime dans le cancer de la prostate
FR2798386B1 (fr) * 1999-09-10 2003-04-25 Didier Raoult Oligonucleotides monocatenaires, sondes, amorces et procede de detection des spirochetes
WO2002006491A1 (fr) * 2000-07-18 2002-01-24 Center For Advanced Science And Technology Incubation, Ltd. Isopentenyl pyrophosphate isomerase
CA2418087A1 (fr) * 2000-08-16 2002-02-21 Markus Fritzsche Utilisation de sequences d'adn microbiennes pouvant identifier des maladies humaines
CN1223602C (zh) 2001-07-13 2005-10-19 一泰医药研究（深圳）有限公司 序列号11的生物活性肽
WO2004005479A2 (fr) * 2002-07-02 2004-01-15 Arizona Board Of Regents Systeme de typage haute resolution pour borrelia pathogene
CN103589650A (zh) 2005-03-18 2014-02-19 米克罗比亚公司 产油酵母和真菌中类胡萝卜素的产生
JP2010503384A (ja) * 2006-09-15 2010-02-04 インターセル アーゲー ボレリア（Ｂｏｒｒｅｌｉａ）抗原
WO2008042338A2 (fr) 2006-09-28 2008-04-10 Microbia, Inc. Production de caroténoïdes dans des levures et des champignons oléagineux
US9297803B2 (en) * 2006-11-01 2016-03-29 Immport Therapeutics, Inc. Compositions and methods for immunodominant antigens
EP2191266A4 (fr) * 2007-09-07 2011-08-03 Univ California Procédés de diagnostic et de criblage concernant borrelia
RU2580299C2 (ru) 2009-06-29 2016-04-10 Дженосеа Биосайенсиз, Инк. Вакцины и композиции, направленные против streptococcus pneumoniae
WO2012100233A1 (fr) 2011-01-20 2012-07-26 Genocea Biosciences, Inc. Vaccins et compositions contre streptococcus pneumoniae
CA2863661C (fr) 2012-02-01 2021-06-01 Biopeptides Corp Peptides diagnostiques pour la maladie de lyme
FR3009683A1 (fr) * 2013-08-14 2015-02-20 Univ Strasbourg Vaccins contre la maladie de lyme
WO2016049148A1 (fr) 2014-09-24 2016-03-31 Wellstat Diagnostics, Llc Compositions et méthodes de diagnostic de la maladie de lyme
EP3135295A1 (fr) * 2015-08-28 2017-03-01 Latvian Biomedical Research and Study Centre Couplage de protéines de borrelia bb0689 à particules pseudo-virales pour génération de vaccin contre la maladie de lyme
US11739388B2 (en) 2016-11-03 2023-08-29 University Of Leicester Phage-based detection of borreliosis and means therefor
EP3643796A1 (fr) * 2018-10-25 2020-04-29 TBD-diagnostics GmbH Diagnostic de la maladie de lyme
CA3175297A1 (fr) 2020-04-13 2021-10-21 Jyotsna Shah Detection de la maladie de lyme
CA3266500A1 (fr) * 2022-09-02 2024-03-07 The Medical College Of Wisconsin, Inc. Utilisation d'épitopes de lymphocytes t immunogènes pour la vaccination et le diagnostic de la maladie de lyme

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK590288D0 (da) * 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
CA2025178A1 (fr) * 1989-10-02 1991-04-03 William G. Weisburg Sondes d'acide nucleique pour la detection des spirochetes de la maladie de lyme

Also Published As

Publication number Publication date
CA2294568A1 (fr) 1998-12-30
AU8151898A (en) 1999-01-04
WO1998059071A1 (fr) 1998-12-30
WO1998058943A1 (fr) 1998-12-30
EP1009859A1 (fr) 2000-06-21
AU8153498A (en) 1999-01-04
EP1012157A1 (fr) 2000-06-28

Similar Documents

Publication Publication Date Title
CA2304925A1 (fr) Polyucleotides de borrelia burgdorferi et sequences correspondantes
JP4254931B1 (ja) Ａ群連鎖球菌およびｂ群連鎖球菌由来の核酸およびタンパク質
RU2284332C2 (ru) Антигенные пептиды neisseria
JP2009165468A (ja) Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓタンパク質および核酸
JP2014068652A (ja) ナイセリア抗原性ペプチド
JP2002508966A (ja) ＮｅｉｓｓｅｒｉａＭｅｎｉｎｇｉｔｉｄｉｓ抗原
JP2008263973A (ja) 淋菌性タンパク質および淋菌性核酸
MXPA02000463A (es) Peptidos antigenicos de meningoccocos.
JP2010046089A (ja) ナイセリア抗原
JP2012147798A (ja) Ｃｈｌａｍｙｄｉａｐｎｅｕｍｏｎｉａｅに対する免疫化
EP2278009A1 (fr) Acides nucléiques et protéines de Streptococcus pneumoniae
US6277381B1 (en) Compounds and methods for the diagnosis and treatment of Ehrlichia infection
ES2383592T3 (es) Toxinas bacterianas ADP-ribosilantes
US6902893B1 (en) Lyme disease vaccines
CA2296814A1 (fr) Polynucleotides et sequences de treponema pallidium
RU2233331C2 (ru) Белок, полученный из neisseria meningitidis, проявляющий свойства антигена, антитело, фрагмент нуклеиновой кислоты (варианты) и содержащая их композиция
EP1003883A1 (fr) Gene regulateur a deux composantes - dont l'histidine kinase - issu du candida albicans
CA2448284A1 (fr) Expression des genes pendant l'adhesion des meningocoques
JP2005289966A (ja) Ａ群連鎖球菌およびｂ群連鎖球菌由来の核酸およびタンパク質
AU8938601A (en) Lyme disease polynucleotides

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued